FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891058291> ?p ?o ?g. }

• W2891058291 endingPage "1063" @default.
• W2891058291 startingPage "1063" @default.
• W2891058291 abstract "Malignant melanoma is a highly aggressive type of cancer that requires radical treatment strategies to inhibit the cancer cell progression and metastasis. In recent years, preclinical research and clinical trials on melanoma treatment have been considerably focused on the adjuvant-based immunotherapy for enhancing the immune response of innate immune cells against cancer cells. However, the clinical outcome of these adjuvant-based treatments is inadequate due to an improper delivery system for these immune activators to reach the target site. Hence, we developed a vaccine formulation containing tumor lysate protein (TL) and poly I:C (PIC) complexed with positively charged poly (sorbitol-co-polyethylenimine (PEI) (PSPEI). The resulting ionic PSPEI-polyplexed antigen/adjuvant (PAA) (PSPEI-PAA) nanocomplexes were stable at the physiological condition, are non-toxic, and have enhanced intracellular uptake of antigen and adjuvant in immature dendritic cells leading to dendritic cell maturation. In the murine B16F10 tumor xenograft model, PSPEI-PAA nanocomplexes significantly suppressed tumor growth and did not exhibit any noticeable sign of toxicity. The level of matured dendritic cells (CD80+/CD86+ cells) in the tumor draining lymph node of PSPEI-PAA treated tumor mice were enhanced and therefore CD8+ T cells infiltration in the tumor were enriched. Additionally, the cytotoxic T lymphocytes (CTLs) assay involving co-culturing of splenocytes isolated from the PSPEI-PAA-treated mice with that of B16F10 cells significantly revealed enhanced cancer killing by the TL-reactivated CTLs compared to untreated control mice bearing tumor. Therefore, we strongly believe that PSPEI-PAA nanocomplexes could be an efficient antigen/adjuvant delivery system and enhance the antitumor immune response against melanoma tumor in the future clinical trials." @default.
• W2891058291 created "2018-09-27" @default.
• W2891058291 creator A5004374498 @default.
• W2891058291 creator A5006720579 @default.
• W2891058291 creator A5015264110 @default.
• W2891058291 creator A5026361494 @default.
• W2891058291 creator A5045010999 @default.
• W2891058291 creator A5053284042 @default.
• W2891058291 creator A5067595080 @default.
• W2891058291 creator A5073490663 @default.
• W2891058291 date "2018-09-25" @default.
• W2891058291 modified "2023-10-18" @default.
• W2891058291 title "Self-Assembled, Adjuvant/Antigen-Based Nanovaccine Mediates Anti-Tumor Immune Response against Melanoma Tumor" @default.
• W2891058291 cites W1010975229 @default.
• W2891058291 cites W111892853 @default.
• W2891058291 cites W130620272 @default.
• W2891058291 cites W1909899750 @default.
• W2891058291 cites W1946637541 @default.
• W2891058291 cites W1975575417 @default.
• W2891058291 cites W1998176389 @default.
• W2891058291 cites W2003466884 @default.
• W2891058291 cites W2003998232 @default.
• W2891058291 cites W2016795009 @default.
• W2891058291 cites W2019823734 @default.
• W2891058291 cites W2020745522 @default.
• W2891058291 cites W2044399538 @default.
• W2891058291 cites W2049923037 @default.
• W2891058291 cites W2060715293 @default.
• W2891058291 cites W2079588017 @default.
• W2891058291 cites W2096808520 @default.
• W2891058291 cites W2098861374 @default.
• W2891058291 cites W2099263305 @default.
• W2891058291 cites W2102284924 @default.
• W2891058291 cites W2117108378 @default.
• W2891058291 cites W2127960112 @default.
• W2891058291 cites W2138869536 @default.
• W2891058291 cites W214287619 @default.
• W2891058291 cites W2147557533 @default.
• W2891058291 cites W2149222201 @default.
• W2891058291 cites W2159648765 @default.
• W2891058291 cites W2239178350 @default.
• W2891058291 cites W2305623036 @default.
• W2891058291 cites W2313318468 @default.
• W2891058291 cites W2400789887 @default.
• W2891058291 cites W2425088556 @default.
• W2891058291 cites W2558257430 @default.
• W2891058291 cites W2596275369 @default.
• W2891058291 cites W2604933953 @default.
• W2891058291 cites W2611218544 @default.
• W2891058291 cites W2612308081 @default.
• W2891058291 cites W2737953224 @default.
• W2891058291 cites W2755360248 @default.
• W2891058291 cites W2781525129 @default.
• W2891058291 cites W2790331032 @default.
• W2891058291 cites W2792649187 @default.
• W2891058291 cites W2793504831 @default.
• W2891058291 cites W4233897861 @default.
• W2891058291 cites W838262002 @default.
• W2891058291 doi "https://doi.org/10.3390/polym10101063" @default.
• W2891058291 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6404041" @default.
• W2891058291 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30960988" @default.
• W2891058291 hasPublicationYear "2018" @default.
• W2891058291 type Work @default.
• W2891058291 sameAs 2891058291 @default.
• W2891058291 citedByCount "14" @default.
• W2891058291 countsByYear W28910582912018 @default.
• W2891058291 countsByYear W28910582912019 @default.
• W2891058291 countsByYear W28910582912021 @default.
• W2891058291 countsByYear W28910582912022 @default.
• W2891058291 countsByYear W28910582912023 @default.
• W2891058291 crossrefType "journal-article" @default.
• W2891058291 hasAuthorship W2891058291A5004374498 @default.
• W2891058291 hasAuthorship W2891058291A5006720579 @default.
• W2891058291 hasAuthorship W2891058291A5015264110 @default.
• W2891058291 hasAuthorship W2891058291A5026361494 @default.
• W2891058291 hasAuthorship W2891058291A5045010999 @default.
• W2891058291 hasAuthorship W2891058291A5053284042 @default.
• W2891058291 hasAuthorship W2891058291A5067595080 @default.
• W2891058291 hasAuthorship W2891058291A5073490663 @default.
• W2891058291 hasBestOaLocation W28910582911 @default.
• W2891058291 hasConcept C147483822 @default.
• W2891058291 hasConcept C154317977 @default.
• W2891058291 hasConcept C185592680 @default.
• W2891058291 hasConcept C202751555 @default.
• W2891058291 hasConcept C203014093 @default.
• W2891058291 hasConcept C2776662205 @default.
• W2891058291 hasConcept C2777658100 @default.
• W2891058291 hasConcept C2777701055 @default.
• W2891058291 hasConcept C2777863537 @default.
• W2891058291 hasConcept C2778297628 @default.
• W2891058291 hasConcept C2778378633 @default.
• W2891058291 hasConcept C2780674031 @default.
• W2891058291 hasConcept C39347974 @default.
• W2891058291 hasConcept C502942594 @default.
• W2891058291 hasConcept C55493867 @default.
• W2891058291 hasConcept C71924100 @default.
• W2891058291 hasConcept C8891405 @default.
• W2891058291 hasConceptScore W2891058291C147483822 @default.

• next